Identifying hepatocellular carcinoma-related genes and pathways by system biology analysis

Irish Journal of Medical Science

Volumn 184, Issue 2, 2015, Pages 357-364

  Wang, P ^a   Ouyang, L ^b   Zheng, L ^a   Wang, Z ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Hepatocellular carcinoma; Molecular network; Transcriptional profiles

Indexed keywords

BIOLOGY; DISEASE COURSE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

CARCINOMA, HEPATOCELLULAR; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84939893081     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-014-1119-y     Document Type: Article

References (46)

1. Adamek A, Kasprzak A, Mikos H et al (2013) The insulin-like growth factor-1 and expression of its binding protein-3 in chronic hepatitis C and hepatocellular carcinoma. Oncol Rep 30(3):1337–1345
2. American Cancer Society (2013) Cancer Statistics 2013, 1–59
3. Asselah T, Bieche I, Laurendeau I et al (2005) Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 129:2064–2075
4. Bevoglu D, Imbeaud S, Maurhofer O et al (2013) Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification. Hepatology 58:229–238
5. Boyault S, Rickman DS, de Reynies A et al (2007) Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45:42–52
6. Chaudhary P, Sharma R, Sahu M et al (2013) 4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway. J Biol Chem 288:20532–20546
7. Coutts AS, La Thangue N (2006) The p53 response during DNA damage: impact of transcriptional cofactors. BioChem Soc Symp 73:181–189
8. Drozoy I, Bornschein J, Wex T et al (2012) Functional and topological properties in hepatocellular carcinoma transcriptome. PLoS ONE 7:e35510
9. Dihal AA, van der Woude H et al (2008) Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis. Proteomics 8(1):45–61
10. Gentleman RC, Carey VJ, Huber W, Hahne F (2009) Genefilter: methods for filtering genes from microarray experiments. R Package Version 1.24.2., Bioconductor 2.6. http://bioc.ism.ac.jp/2.6/bioc/html/genefilter.html. Accessed 20 Aug 2013
11. Han YC, Zheng ZL et al (2013) Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1. J Pathol 230(2):184–193
12. Halaby MJ, Yang DQ (2007) p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene 395:1–7
13. Hayashi M, Nomoto S et al (2014) Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma. BMC Cancer 14(1):108
14. Huang C, Wang Y et al (2013) Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma. J Proteome Res 12(4):1838–1846
15. Jiang J, Gusev Y, Aderca I et al (2008) Association of Micro RNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14:419–427
16. Jiang JG, Chen CL, Card JW et al (2005) Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res 65:4707–4715
17. Kao YH, Chen CL, Jawan B et al (2010) Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis. J Hepatol 52(1):96–105
18. Komatsu Y, Waku T, Iwasaki N et al (2012) Global analysis of DNA methylation in early-stage liver fibrosis. BMC Med Genomics 5:5
19. Lai KK, Shang S, Lohia N et al (2011) Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models. PLoS Genet 7:e1002147
20. Lee SY, Kim JW et al (2008) Microtubule-associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells. FEBS Lett 582(19):2826–2832
21. Levine AJ, Puzio-Kuter AM (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330:1340–1344
22. Matsuo M, Terai K et al (2012) Designation of enzyme activity of glycine-N-acyltransferase family genes and depression of glycine-N-acyltransferase in human hepatocellular carcinoma. Biochem Biophys Res Commun 420(4):901–906
23. Mazurek S (2011) Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 43:969–980
24. Midorikawa Y, Makuuchi M, Tang W et al (2007) Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges. World J Gastroenterol 13:1487–1492
25. Oh JH, Kim YB, Gurnani P et al (2008) Biomarker selection and sample prediction for multi-category disease on MALDI-TOF data. Bioinformatics 24:1812–1818
26. Pei Y, Zhang T, Renault V et al (2009) An overview of hepatocellular carcinoma study by omics-based methods. Acta Biochim Biophys Sin (Shanghai) 41:1–15
27. Rehem RN, El-Shikh WM (2011) Serum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma. Hepatogastroenterology 58:949–954
28. Smyth GK (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (eds) Bioinformatics and computational biology solutions using R and bioconductor. Springer, New York, pp 397–420
29. Sun S, Lee NP, Poon RT et al (2007) Oncoproteomics of hepatocellular carcinoma: from cancer markers’ discovery to functional pathways. Liver Int 27:1021–1038
30. Szklarczyk D, Franceschini A, Kuhn M et al (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39:D561–D568
31. Tanaka S, Moqushi K, Yasen M et al (2011) Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: a prospective, multicenter study. Hepatology 54:1273–1281
32. Taniquchi K, Yamada T, Sasaki Y et al (2010) Genetic and epigenetic characteristics of human multiple hepatocellular carcinoma. BMC Cancer 10:530
33. Tavazoie S, Huqhes JD, Campbell MJ et al (1999) Systematic determination of genetic network architecture. Nat Genet 22:281–285
34. Troyanskaya O, Cantor M, Sherlock G et al (2001) Missing value estimation methods for DNA microarrays. Bioinformatics 17:520–525
35. Wang L, Huang J, Jiang M (2010) RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis/cirrhotic liver tissues and human hepatocellular carcinoma (HCC). Cell Physiol Biochem 26:303–310
36. Wang W, Sun Q, Wu Z et al (2013) Mitochondrial dysfunction-related genes in hepatocellular carcinoma. Front Biosci (Landmark Ed) 18:1141–1149
37. Wang Z, Jiang Y, Guan D et al (2013) Critical roles of p53 in epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma cells. PLoS ONE 8:e72486
38. Wei RR, Zhang MY, Rao HL et al (2012) Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma. Med Oncol 29:2737–2743
39. Wu Z, Irizarry RA, Gentleman R et al (2004) A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 99:909–917
40. Wurmbach E, Chen YB, Khitroy G et al (2007) Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45:938–947
41. Yang W, Xia Y, Ji H et al (2011) Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature 480:118–122
42. Zambon AC, Gai S, Ho I et al (2012) GO-Elite: a flexible solution for pathway and ontology over-representation. Bioinformatics 28:2209–2210
43. Zhang X, Lu X, Shi Q et al (2006) Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data. BMC Bioinformatics 7:197
44. Zhang Y, Wang S, Li D et al (2011) A systems biology-based classifier for hepatocellular carcinoma diagnosis. PLoS ONE 6:e22426
45. Zhou HJ, Liu YK, Li Z et al (2007) Analysing protein–protein interaction networks of human liver cancer cell lines with diverse metastasis potential. J Cancer Res Clin Oncol 133:663–672
46. Zhou SF, Wang B, Yang LP et al (2010) Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev 42:268–354